Modulation of huntingtin expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsGene Hung, C. Frank Bennett, Susan M. Freier, Holly Kordasiewicz, Lisa Stanek, Don W. Cleveland, Seng H. Cheng, Lamya Shihabuddin
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, compounds, and compositions for reducing expression of huntingtin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate Huntington's disease, or a symptom thereof.
Claims25
-76. (canceled)
A method for reducing the rate of progression of one or more symptoms of Huntington's disease in a subject in need thereof, comprising administering to the subject a compound comprising a modified oligonucleotide consisting of 12 to 30 linked nucleosides, wherein said compound specifically hybridizes to a nucleic acid sequence of the huntingtin gene.
Dependencies are inferred from the claim text.